Multi-Targeted Tyrosine Kinase Inhibitor Sorafenib. Application Experience in Kidney Cancer With Lung Metastases. Вопр. онкол. 2016, 62 (1), 154-156. https://doi.org/10.37469/0507-3758-2016-62-1-154-156.